目的探讨急性心肌梗死直接经皮冠脉介入治疗（PCI）的疗效，方法及安全性。
To investigate the effect, method and safety of direct percutaneous coronary intervention (PCI) for the treatment of acute myocardial infarction.
目的探讨65岁以上急性冠脉综合征(ACS)患者经皮冠状动脉介入治疗(pci)的临床疗效。
Objectives To explore the clinical effects of percutaneous coronary interventions (PCI) on elderly patients with acute coronary syndrome (ACS) who were all more than 65 years old.
氯吡格雷是一种抗血小板药物，是新型二磷酸腺苷受体拮抗剂，已广泛应用于急性冠脉综合征和经皮冠状动脉介入治疗的抗血栓治疗。
Clopidogrel is a kind of drug to resistant platelet, it is a new ADP receptor resistant. It has been used in acute coronary syndrome and percutaneous coronary intervention patients widely.
氯吡格雷是一种抗血小板药物，是新型二磷酸腺苷受体拮抗剂，已广泛应用于急性冠脉综合征和经皮冠状动脉介入治疗的抗血栓治疗。
Clopidogrel is a kind of drug to resistant platelet, it is a new ADP receptor resistant. It has been used in acute coronary syndrome and percutaneous coronary intervention patients widely.
应用推荐